Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study.Journal of Clinical Oncology, 2008, 26 (7), pp.1080-5. ⟨10.1200/JCO.2007.12.8223⟩
Journal articles
inserm-00376398v1
|
||
|
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancerSupportive Care in Cancer, 2018, 26 (1), pp.81-89. ⟨10.1007/s00520-017-3816-3⟩
Journal articles
inserm-01819309v1
|
||
|
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancerCancer Medicine, 2016, 5 (4), pp.676-683. ⟨10.1002/cam4.635⟩
Journal articles
hal-01312777v1
|